PubMed

FDA 510(k) clearances for chronic pain devices: regulatory trends and safety outcomes from 1976-2025.

PMID: 41702410 · 2026-02-20

B, a, s, s, e, l, , A, l, m, a, r, i, e, ;, , F, e, l, i, p, e, , F, r, e, g, n, i

학술지Expert review of medical devices

연도2026-02-20

PMID41702410

초록

We characterized regulatory and safety patterns of FDA 510(k)-cleared chronic pain devices over five decades. We analyzed 1718 chronic pain devices cleared from 1976-2025, assessing device modality, review times, recalls (2002-2025), and market concentration (Herfindahl - Hirschman Index, HHI). Most devices were noninvasive neuromodulation (1,486 [86.5%]), followed by invasive neuromodulation (162 [9.4%]), energy-based (67 [3.9%]), and digital therapeutics (3 [0.2%]). Median FDA review was 117 d

공식 출처

PubMed에서 보기 →

데이터는 PubMed / NCBI에서 제공됩니다. 전문과 최신 정보는 반드시 공식 기록을 확인하세요.